Fludarabine and Alemtuzumab or Cyclophosphamide Followed by Peripheral Blood Stem Cell Transplant or Alemtuzumab in Treating Patients With Advanced or Progressive Chronic Lymphocytic Leukemia

NCT00462332 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

86

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: Fludarabine
DRUG: Campath
PROCEDURE: Transplant
DRUG: Campath
DRUG: Fludarabine
DRUG: Campath
DRUG: Campath

Sponsor

Gruppo Italiano Malattie EMatologiche dell'Adulto